S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Trovagene Expands Collaboration with Genomac to Demonstrate Clinical Utility in Lung and Colorectal Cancer Treatment Monitoring (2015/1/21)|
|Clinical Study Results Presented at the 2015 Gastrointestinal Cancer Symposium Support Utility of Trovagene's Precision Cancer Monitoring Platform in Colorectal and Pancreatic Cancer Patients (2015/1/20)|
|Clinical Results Demonstrate High Sensitivity of Trovagene's Urine-Based HPV Assay for the Detection of High Risk HPV and Pre-Cancerous Cervical Lesions (2015/2/9)|
|Former President of BIO Joins Trovagene's Board of Directors (2015/1/6)|
|Trovagene and City of Hope Collaborate To Monitor EGFR Mutational Status in Lung Cancer Patients (2015/1/8)|
|Trovagene Announces Presentation of Clinical Data at the 56th American Society of Hematology Annual Meeting (2014/12/4)|
|Trovagene Collaborates with UC San Diego Moores Cancer Center to Demonstrate Clinical Utility of Detecting and Monitoring EGFR Mutations in Lung Cancer Patients (2015/1/12)|
|Trovagene, Inc. Announces Pricing of Public Offering of Common Stock (2015/2/6)|
|Trovagene, Inc. Announces Closing of Public Offering of Common Stock (2015/2/11)|
|Trovagene's Chief Scientific Officer to Present Precision Cancer Monitoring (SM) Platform Overview at the Personalized Medicine World Conference (2015/1/26)|
Click above to view more mutual fund data and stats for trov - TrovaGene Inc.